Clinical trial
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute…
NCT00096135 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00096135 |
|---|---|
| Title | Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes |
| Official title | Treatment of Late Isolated Extramedullary Relapse From Acute Lymphoblastic Leukemia (ALL) (Initial CR1≥ 18 Months) |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, leucovorin calcium, mercaptopurine, methotrexate, pegaspargase and 3 more |
| Enrollment | 168 |
| Start date | Nov 1, 2004 |
| Primary completion | Sep 1, 2013 |
| First posted | Nov 9, 2004 |
| Last update posted | Mar 21, 2017 |
| Countries | Australia, Canada, New Zealand, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: